Small caps round-up: DQ Entertainment, Tristel, ReNeuron

DQ Entertainment, a producer of animation, visual effects, game art and live action entertainment content for the global media and entertainment industry, has won three new contracts for co-production. The first is with French broadcaster TF1 for the new 3D animated TV series of Robin Hood, the second is with Minika ATV for its new kids network in Turkey and the third is with Gaurmont Alphanim for the new 3D animated CGI TV series "Lanfeust". Tristel, a manufacturer of infection control, contamination control and hygiene products, has terminated its supply arrangement with Medichem International for disinfectants and cleaning products. Tristel will now directly market these products to veterinary practices, hospitals under Tristel related brands. Tristel is now free to address the veterinary market directly and to broaden its product offering within areas that it had not been directly involved with, including its core hospital marketplace. ReNeuron Group, a UK-based stem cell company, has announced a firm placing to raise up to £9.4m before expenses with the shares being sold at 4p each. The issue price represents a discount of around 21.2% to the mid-market closing price of 5.075p on the day before the placing was announced. In addition, investors in the placing are being issued warrants to subscribe for ordinary shares, which could raise up to another £8.1m for the company, before expenses, if the warrants are exercised. The company also said that to date no adverse reactions had been seen in the five stroke patients who have been administered with its ReN001 stem cell therapy treatment. The company expects to be able to apply for a phase II study next year. NR